Related Experiment Videos

[Invasive treatment methods in therapy and angiogenic sepsis]

Terapevticheskii Arkhiv
|January 1, 1987
PubMed

Insights

Vascular access device infections, including sepsis, occurred in 0.43% of patients. Staphylococcus aureus was identified as the primary cause of angiogenic sepsis, necessitating improved prevention strategies.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Clinical Medicine

Context:

  • Vascular access devices like catheters, shunts, and fistulas are crucial in patient care.
  • Infection associated with these devices poses a significant clinical challenge.
  • Understanding the microbial etiology and clinical presentation of device-related infections is essential.

Purpose:

  • To investigate the incidence of sepsis in patients with vascular access devices.
  • To identify microorganisms responsible for device-related infections and sepsis.
  • To describe the clinical features, diagnosis, and prevention of angiogenic sepsis.

Summary:

  • Sepsis developed in 0.43% of 1850 patients with vascular access devices.
  • Catheter and shunt infections were more common than sepsis.
  • Bacteriological analysis of 300 catheters revealed microbial growth in 27.7%, with Staphylococcus aureus identified as the cause of angiogenic sepsis.

Impact:

  • Highlights the importance of monitoring and preventing infections associated with vascular access devices.
  • Provides insights into the clinical manifestations and early diagnostic signs of angiogenic sepsis.
  • Emphasizes the need for effective strategies for the pathogenesis and prevention of angiogenic sepsis.

Related Concept Videos